Clinical Trial Update: Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer [Phase 2]

View source ↗

Summary

Phase II study evaluating bevacizumab with capecitabine and oxaliplatin in metastatic colorectal cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)
• Capecitabine (Xeloda) (Capecitabine)
• Oxaliplatin (Eloxatin) (oxaliplatin)

Snippet

Sponsor: Asan Medical Center | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED